title: Learning more from the dabigatran concentrations in the RE-LY study.
authors.forename: Paul K L
authors.initials: PK
authors.lastname: Chin
authors.forename: Daniel F B
authors.initials: DF
authors.lastname: Wright
authors.forename: Matthew P
authors.initials: MP
authors.lastname: Doogue
authors.forename: Evan J
authors.initials: EJ
authors.lastname: Begg
mesh_terms: D000991:Antithrombins / Q000097:blood*; D001562:Benzimidazoles / Q000097:blood*; D005260:Female; D006470:Hemorrhage / Q000453:epidemiology*; D006801:Humans; D008297:Male; D011725:Pyridines / Q000097:blood*; D020521:Stroke / Q000453:epidemiology*
chemical_list: D000991:Antithrombins; D001562:Benzimidazoles; D011725:Pyridines